OFD 2022
Program
Note: Program is subject to change.
To view session descriptions click on "More Info" and then click on the presenter's name to view their biography.
Saturday
October 22, 2022
All times indicated are Eastern Daylight Times (EDT).
Presentation Summary
A basic overview of radiation oncology, including how radiation therapy works, the different types of radiotherapy used in cancer patients, the logistics of treatment, and how treatment has evolved over the years.
Learning Objectives
- A participant will be able to understand the mechanism of action for radiotherapy treatment.
- A participant will be able to describe the common types of radiotherapy and how they are delivered to patients.
- A participant will be able to describe the roles of curative and palliative radiotherapy in cancer patients.
Presentation Summary
Pharmacy Technicians working in clinical trials is a well established practice at the Ottawa Hospital Cancer Centre, however, in many other centres this role may not exist.
During this presentation I will provide information and details about this exciting position and how it is conducted within the scope of a Pharmacy Technician. One of this presentation’s goals is that Pharmacy Technicians and their employers can take this information back to their workplaces and expand the role of Pharmacy Technicians working in their own Pharmacy Departments.
Learning Objectives
- Describe the history behind the role of Pharmacy Technicians working in clinical trials
- Explore the wide variety of tasks involved with clinical trials
- Identify the skills required to effectively perform as a Pharmacy Technician in clinical trials
- Outline the challenges involved with a Pharmacy Technician clinical trials role
Moderator: Scott Edwards, Clinical Oncology Pharmacist Specialist, Dr H Bliss Murphy Cancer Center, Memorial University, Newfoundland and Labrador
Presentation Summary
There have been a lot of practice-changing data released recently for the management of patients with HR+ HER2- advanced breast cancer. Join us for a dynamic panel discussion, during which moderator Dr. Scott Edwards, and speakers Dr. Sudha Rajagopal and Dr. Tom McFarlane review the latest CDK4/6 inhibitor data and what the latest developments mean for your practice.
Learning Objectives:
- Review the latest clinical evidence for HR+ HER2- metastatic breast cancer patients
- Discuss the practical implication of this latest evidence for pharmacist
- Provide case-based best practices for optimizing patient care within the pharmacy
Presentation Summary
Oncology pharmacists and pharmacy technicians collaborate with patients and members of the healthcare team who have a wide variety of visible and invisible diverse traits. Understanding diversity and demonstrating inclusive behaviour is essential in developing trusting, effective communication and relationships.
This presentation will allow oncology pharmacy team members to gain an understanding of the multidimensional factors of diversity and the impact of developing inclusive behaviour. Elements of diversity and inclusion including bias, allyship and antiracism will be discussed.
Learning Objectives
- To describe the negative impacts of unconscious bias and lack of inclusion on patients and peers.
- To identify strategies to open lines of communication and gain trusting relationships with patients and peers with diverse traits.
- To be inspired to learn more about diversity and inclusion and positively affect the experiences of patients and peers.
Presentation Summary
Throughout this presentation, listeners will gain a high level understanding of the different types of lymphomas, including Hodgkin and Non-Hodgkin lymphoma and subtypes. The presentation will explore lymphoma diagnosis and management, include basic pathology findings, symptoms, common treatment options and current clinical challenges.
Learning Objectives
- Define lymphoma
- Differentiate between Hodgkin lymphoma (HL) and Non-Hodgkin lymphoma (NHL)
- Understand clinical features of and subtypes of HL& NHL
- Explain the first line management of common subtypes of both HL & NHL
Presentation Summary
This discussion will provide an overview on the history of our Hospital Pharmacy chemotherapy processes, and the steps we have taken over the years to mitigate near misses in chemotherapy preparation.
Learning Objectives
- Describe the workflow involved in chemotherapy preparation and how it can contribute to near misses
- Discuss how computers and technology can have an impact on near misses
- Identify human factors that can relate to chemotherapy preparation near misses
Presentation Summary
Melissa Lo and Christopher Tse will present a pharmacist-tailored overview of intrathecal chemotherapy. The presentation will briefly review the physiology and pharmacokinetic implications of the blood brain barrier before diving into the indications, pharmacology, preparation, administration, and complications of intrathecal chemotherapy. Specific questions which will be addressed include: What is the role of intrathecal chemotherapy in treatment of cancer? How is intrathecal chemotherapy properly prepared? What are the different methods of administering intrathecal chemotherapy? How does one choose between different chemotherapy agents for intrathecal use?
Learning Objectives
- Review physiology and pharmacokinetic implications of the blood brain barrier.
- Understand which medical conditions require intrathecal chemotherapy for treatment.
- Evaluate the proceed parameters required to administer intrathecal chemotherapy.
- Distinguish between different chemotherapeutic agents used in intrathecal chemotherapy.
- Understand the treatment of complications related to intrathecal chemotherapy.
Moderator: Carla Pensack, Oncology Pharmacist, Cancer Care Manitoba
Presentation Summary
CLL may be viewed as a chronic disease; a chronic cancer where the goal is to control it by using lifelong surveillance and therapy.
During this symposium we will ask the question, “What would you do next?” in your approach with patients. Besides recognizing drug interactions with CLL treatments, attendees will also incorporate disease interactions as part of their pharmacy monitoring plan.
Learning Objectives
By attending the symposium today, attendees will be able to:
- Use case examples to review the choices available to treat CLL and recognize how that choice is made by patient and prescriber.
- Develop a pharmacy care plan to support patients starting therapy for CLL and what may be different about their care plan for a patient already established on a CLL therapy.